Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry (Q42846272)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 July 2013

edit

Language	Label	Description	Also known as
English	Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry	scientific article published on 24 July 2013

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

editorial

0 references

title

Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

main subject

antibody

1 reference

based on heuristic

inferred from title

author

Janice M. Reichert

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

author name string

Alain Beck

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

publication date

24 July 2013

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

published in

Monoclonal Antibodies

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

volume

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

issue

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

page(s)

621-623

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

cites work

Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

The continuum of comparability extends to biosimilarity: how much is enough and what clinical data are necessary?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Characterization of therapeutic antibodies and related products.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Biosimilars: what clinicians should know

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Quantitative structural characterization of local N-glycan microheterogeneity in therapeutic antibodies by energy-resolved oxonium ion monitoring

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Analytical aspects of biosimilarity issues of protein drugs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

An innovative approach for the characterization of the isoforms of a monoclonal antibody product

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Acceptable changes in quality attributes of glycosylated biopharmaceuticals

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Worldwide experience with biosimilar development

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Biosimilar, biobetter and next generation therapeutic antibodies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Strategies and challenges for the next generation of therapeutic antibodies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

27 May 2018

Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

16 August 2018

A global comparability approach for biosimilar monoclonal antibodies using LC-tandem MS based proteomics

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

16 August 2018

8(th) Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

16 August 2018

Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

16 August 2018

Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851211

retrieved

16 August 2018

Toward biosimilar monoclonal antibodies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23924791

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biosimilars-why terminology matters

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23924791

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The state of the art in the development of biosimilars

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23924791

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Setting the stage for biosimilar monoclonal antibodies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23924791

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rise of the biosimilar

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23924791

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab Fab and Fc N-glycan fast characterization using IdeS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23924791

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.4161/MABS.25864

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

PMC publication ID

3851211

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

PubMed publication ID

23924791

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851211

retrieved

8 November 2017

ResearchGate publication ID

255706192

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42846272&oldid=2073265360"